Phase I Biomarker Analysis Results of MORAb-202 (Farletuzumab Ecteribulin) Effects on Vascular Remodeling and Immune Modulation in Patients With Ovarian Cancer

Y. Zhang, S. Li, T. Uenaka, K. Furuuchi, K. Yonemori, T. Shimizu,S. Nishio, M. Yunokawa,K. Matsumoto, K. Takehara, K. Hasegawa, Y. Hirashima, H. Kato, Y. Otake, T. Miura, J. Matsui

European Journal of Cancer(2022)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要